...
首页> 外文期刊>Pain research & management: the journal of the Canadian Pain Society = journal de la socie?te? canadienne pour le traitement de la douleur >Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial
【24h】

Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial

机译:胶原蛋白和利多卡因肌内注射的比较,效率降低了肌肌肌肉中的肌筋疼痛:随机,单盲对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objective. A novel option for myofascial pain (MFP) management and muscle regeneration is intramuscular collagen injections. The aim of the study was to evaluate the efficiency of intramuscular injections of collagen and lidocaine in decreasing MFP within masseter muscles. Methods. Myofascial pain within masseter muscles was diagnosed on the basis of the Diagnostic Criteria for Temporomandibular Disorders (II.1.A. 2 and 3). A total of 43 patients with diagnosed MFP within masseter muscles were enrolled to the study (17 male and 26 female, 40?±?3.8 years old) and randomly divided into three groups. The first group received injections using 2?ml of collagen MD Muscle (Guna), the second group received 2?ml of 2% lidocaine without a vasoconstrictor, and the third group 2?ml of saline as a control (0.9% NaCl). All patients received repeated injections at one-week intervals (days 0 and 7). The visual analogue scale was used to determine pain intensity changes during each follow-up visit (days 0, 7, and 14) in each group. The masseter muscle activity was measured on each visit (days 0, 7, and 14) with surface electromyography (sEMG) (Neurobit Optima 4, Neurobit Systems). Results. We found that sEMG masseter muscle activity was significantly decreased in Group I (59.2%), less in Group II (39.3%), and least in Group III (14%). Pain intensity reduction was 53.75% in Group I, 25% in Group II, and 20.1% in Group III. Conclusions. The study confirmed that intramuscular injection of collagen is a more efficient method for reducing myofascial pain within masseter muscles than intramuscular injection of lidocaine.
机译:背景和目标。肌菌疼痛(MFP)管理和肌肉再生的新选择是肌肉内胶原蛋白。该研究的目的是评估胶原蛋白和利多卡因肌肉内注射液滴在肌肉肌肉中的MFP中的效率。方法。肌肉肌肉内的肌筋疼痛是在颞下颌疾病的诊断标准的基础上诊断出来(II.1.A.2和3)。共有43例患有肌肉肌肉的MFP诊断的患者纳入研究(17名男性和26名女性,40°?3.8岁),随机分为三组。第一个组接受使用2?Ml胶原MD肌肉(GUA)的注射,第二组在没有血管收缩剂的情况下察觉2?Ml 2%Lidocaine,第三组2?Ml盐水作为对照(0.9%NaCl)。所有患者以一周的间隔(第0天和第7天)接受重复注射。视觉模拟标度用于确定每个组中的每次随访访问期间的疼痛强度变化(天0,7和14)。每次访问(SEMG)(METOUBIT OPTOPA 4,Neurobit Systems)的每次访问(日0,7和14天)上测量肌肉肌肉活性。结果。我们发现,II组(59.2%),II组(39.3%),III组(39.3%),少量肌肉肌肉活性显着降低(39.3%)。 II族II组疼痛强度降低为53.75%,25%,III组中的20.1%。结论。该研究证实,肌肉注射胶原蛋白是一种更有效的方法,用于减少肌肉肌肉内的肌动虫疼痛而不是肌内注射利多卡因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号